A National Prospective Cohort of Patients With Idiopathic Nephrotic Syndrome Beginning in Childhood.
University Hospital, Limoges
1,180 participants
Mar 13, 2020
OBSERVATIONAL
Conditions
Summary
Pediatric idiopathic nephrotic syndrome (INS) is a rare disease for which the optimal therapeutic strategy has not yet been defined. A network of clinicians treating complicated forms of this disease (grouped within the Société de Néphrologie Pédiatrique, SNP) exists, but to date there is no prospective cohort following up these patients that would facilitate the development of cohort-nested trials. This absence of structured follow up makes it difficult to set up prospective studies. The main objective is to create a prospective cohort of pediatric INS patients to collect cases treated in SNP centers, to study their epidemiological characteristics, and to provide a basis for comparison for future cohort-nested trials.
Eligibility
Inclusion Criteria6
- Patient under 18 years of age
- With idiopathic nephrotic syndrome (according to SPN criteria) beginning after January 1, 2018
- Child seen at least once in consultation or hospitalization by a pediatrician member of the Society of Pediatric Nephrology
- Residing in France
- Consent signed by parents and patient's agreement to participate (if of age)
- Affiliated to a social security system.
Exclusion Criteria1
- Refusal of the patient or legal representatives to participate in the cohort
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The study consists in collecting clinical, biological, psychological and social data of INS pediatric patients. A bio collection is also created: blood, urine, hair and nails will be collected at the beginning of the INS (before starting immunosuppressive treatment).
Locations(48)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04207580